Home › Infertility › NCT07020546

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study

Who can join

Ages 18 to 47 · Women · Healthy volunteers welcome

Inclusion Criteria:

* No none contraindications to IVF or PRP treatment
* Adequate ovarian reserves and AMH level
* Willingness to undergo two IVF cycles and oPRP treatment

Exclusion Criteria:

* Anovulation due to menopause or perimenopause
* Any health conditions that are contraindicated for IVF or oPRP treatment

About the study

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

What is being tested

• Ovarian Platelet-rich plasma (PRP) injections (procedure)

Sponsor: Generation Next Fertility · Participants: 180 · Started: Jul 8, 2025

Contact the study team

• Alicia L Broussard, PhD · Phone: 3174456958
• Jesse Hade, MD · Phone: 2126410906

Official record on ClinicalTrials.gov — NCT07020546

Locations in the U.S.

Conditions

• Infertility

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.